GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (XTER:BNN) » Definitions » FCF Yield %

BRAIN Biotech AG (XTER:BNN) FCF Yield % : -3.36 (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is BRAIN Biotech AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BRAIN Biotech AG's Trailing 12-Month Free Cash Flow is €-1.85 Mil, and Market Cap is €55.06 Mil. Therefore, BRAIN Biotech AG's FCF Yield % for today is -3.36%.

The historical rank and industry rank for BRAIN Biotech AG's FCF Yield % or its related term are showing as below:

XTER:BNN' s FCF Yield % Range Over the Past 10 Years
Min: -6.55   Med: -2.43   Max: -0.42
Current: -3.36


During the past 9 years, the highest FCF Yield % of BRAIN Biotech AG was -0.42%. The lowest was -6.55%. And the median was -2.43%.

XTER:BNN's FCF Yield % is ranked worse than
68.57% of 1562 companies
in the Chemicals industry
Industry Median: 0.72 vs XTER:BNN: -3.36

BRAIN Biotech AG's FCF Margin % for the quarter that ended in Mar. 2024 was -3.72%.


BRAIN Biotech AG FCF Yield % Historical Data

The historical data trend for BRAIN Biotech AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG FCF Yield % Chart

BRAIN Biotech AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -4.63 -5.41 -2.37 -7.31 -7.40

BRAIN Biotech AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.69 4.83 1.13 -13.24 -2.86

Competitive Comparison of BRAIN Biotech AG's FCF Yield %

For the Specialty Chemicals subindustry, BRAIN Biotech AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BRAIN Biotech AG's FCF Yield % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BRAIN Biotech AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BRAIN Biotech AG's FCF Yield % falls into.



BRAIN Biotech AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BRAIN Biotech AG's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-6.856 / 92.6334
=-7.40%

BRAIN Biotech AG's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.539 * 4 / 75.373875
=-2.86%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BRAIN Biotech AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BRAIN Biotech AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of BRAIN Biotech AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BRAIN Biotech AG (XTER:BNN) Business Description

Traded in Other Exchanges
Address
Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.
Executives
Dr. Michael Majerus Supervisory Board
Dr. Georg Kellinghusen Supervisory Board
Michael Schneiders Board of Directors
Adriaan Moelker Board of Directors
Lukas Linnig Board of Directors

BRAIN Biotech AG (XTER:BNN) Headlines

No Headlines